Fibonacci Retracement

Consumer Staples
Defensive Stocks
Dividends
Fibonacci Retracement
Food Products
Fundamental Analysis
Grocery
Supermarkets
Technical Analysis
Value Investing
Value Stocks

GIS value proposition is getting better every day

What tends to generate less buzz in market news and other media outlets than the attention that is focused on the Tech sector that has dominated most of the past year is another COVID-driven trend that I think is also very important and has a few different interesting layers to it. Stay-at-home orders, shuttered restaurants […]

Read More
Cloud-based
Computer Networks
Dividends
Fibonacci Retracement
Fundamentals
Tech Industry
Tech Stocks
Technical Analysis
Technology
Value Investing
Value Stocks

JNPR is -14% below its 52-week high – is it a good time to buy?

The Tech sector has been one of the top-performing areas of the market for the past year, which isn’t too surprising given the way Technology has enabled the corporate world to shift operational models to remote, work-from-home, and flexible working arrangements because of the ongoing pandemic. As analyst, I’ve been interested to see how it […]

Read More
Consumer Staples
Defensive Stocks
Dividends
Economic Trends
Fibonacci Retracement
Food Products
Fundamental Analysis
Grocery
Supermarkets
Technical Analysis
Value Investing
Value Stocks

K’s stabilizing downward trend looks like a good opportunity to work with a good value stock

I’ve been writing quite a bit lately about positioning yourself conservatively to keep trading in a functional way even when the market is very extended. The commentary lately, and even market activity (increasing bond yields, rising inflation uncertainty), seems to be grappling with this question too. One of the biggest elements that comes to play […]

Read More
Consumer Discretionary
Dividends
Fibonacci Retracement
Fundamental Analysis
Home Goods
Housewares
Technical Analysis
Value Investing
Value Stocks

Where is NWL’s bargain price today?

One of the open questions of the past year has been about the point in time where questions, discussions and commentary about the economy and the world don’t continue to revolve around the pandemic. That question remains unanswered, but as an analyst, part of my job is to sift through the relentless, constant stream of […]

Read More
Biopharmaceuticals
Biotech
Dividends
Fibonacci Retracement
Fundamental Analysis
Health
HeathCare
Medical
Pharmaceuticals
Technical Analysis
Value Investing
Value Stocks

Negative Net Income is a fundamental red flag for BMY – but it’s still a good long-term value

There is a lot of fundamental data that I rely on to help paint an overall picture about underlying strength of any stock I might consider using for a value-based investment. While some fundamental investors prefer to work with easy-to-reference, quick-glance data like earnings per share, I prefer to expand my view of a company’s […]

Read More
Biopharmaceuticals
Biotech
Defensive Stocks
Dividends
Fibonacci Retracement
Fundamental Analysis
Immunology
Pharmaceuticals
Technical Analysis
Vaccines
Value Investing
Value Stocks

PFE is down -20% in the last two months – is it a bargain?

It has been interesting to see how market commentary seems to have shifted as much as possible away from COVID-related news since the beginning of the year. In one sense, I think that could be a good thing, since there are a lot of issues, economic, political, and otherwise that are worthy of attention. This […]

Read More
Chemicals
Dividends
Fibonacci Retracement
Fundamental Analysis
Materials
Risk
Technical Analysis
Value Investing
Value Stocks

HUN’s fundamentals are getting better – what about its value?

Over the last year, one of the best sectors of the stock market’s rally back to, and even above pre-pandemic levels has been the Materials sector. Beginning in mid-May to a peak last week, the sector had increased in value by nearly double by early January, as measured by the S&P 500 Materials Sector SPDR […]

Read More
Auto Industry
Automotive Electronics
Discretionary
Dividends
Electric Vehicles
Fibonacci Retracement
Fundamental Analysis
Technical Analysis
Value Investing
Value Stocks

BWA might be a better value than standard metrics suggest

Even before the coronavirus pandemic started to take down entire sectors of the economy beginning in February, the Auto industry was experiencing quite a bit of bearish pressure. Sales were down globally, reflecting economic slowing in various parts of the world as well as the effects of an extended trade war between the U.S. and […]

Read More
Auto Industry
Consumer Discretionary
Discretionary
Fibonacci Retracement
Fundamental Analysis
Manufacturing
Technical Analysis
Value Investing
Value Stocks

GT’s fundamentals are getting stronger – what about its value proposition?

It isn’t too hard to argue that one of the most severely impacted industries over the last year as a result of coronavirus has been the auto industry. That shouldn’t come as much of a surprise, considering that for most of last spring, shutdown mandates and shelter-in-place orders brought global economic activity to a standstill. […]

Read More
conglomerates
Dividends
Fibonacci Retracement
Fundamental Analysis
Industrial Machinery
Industrial Sector
Industrials
Technical Analysis
Value Investing
Value Stocks

Where is CAT’s bargain price?

There are a lot of ways to look at a company and evaluate them for fundamental strength. Traditional metrics, including many of the ones that I rely on for the stocks that I analyze, measure everything from sales and earnings growth to how much productivity the company realizes per employee. You can break down the […]

Read More
Cloud-based
Dividends
Electronics
Fibonacci Retracement
Fundamental Analysis
Mobile Devices
Semiconductor
Tech Industry
Tech Stocks
Technical Analysis
Technology
Value Investing
Value Stocks

Where is JBL’s value price?

The Tech sector has been leading the market higher throughout the past year, with plenty of momentum continuing into 2021. As measured by the S&P 500 Technology Sector SPDR (XLK), the sector is up a little over 6% through the first five weeks of 2021. It has also more than doubled in value from its […]

Read More
Broadband
Dividends
Fibonacci Retracement
Fundamental Analysis
Internet Of Things
Smart Devices
Technical Analysis
Technology
Telecommunication
Value Investing
Value Stocks
Web Accessibility
Wireless

VZ’s bargain status might just be too good to ignore

The market pushed to a new, all-time high to start this week, as investors and analysts seem to be betting on the likelihood of a new, Democrat-driven set of stimulus to help the economy continue to recover from its COVID-induced recession – particularly as measured by unemployment numbers, which still remain near 800,000 per week. […]

Read More
Auto Industry
Construction
Dividends
Electric Vehicles
Fibonacci Retracement
Fundamental Analysis
Industrial Machinery
Real Estate
Technical Analysis
Trucking
Value Investing
Value Stocks

PCAR is a wonderful company at the top of its long-term trend – is the stock a fair price?

As a value-focused investor, I’ve read a lot of books and studied the methods of a lot of well-known money managers who have found success using the same reliance on finding bargains in any market. One of the most successful in the entire history of the U.S. stock market, and arguably the most famous of […]

Read More
Business Services
Dividends
Economy
Employment
Fibonacci Retracement
Fundamental Analysis
Technical Analysis
Value Investing
Value Stocks

MAN has nearly doubled from its bear market low and could still offer good value

Over the last several years, one of the biggest benchmarks the Fed has used to evaluate the need to raise, lower or maintain their interest rate policy has been the employment rate. Every month, the market seems to hold its breath as a new set of unemployment and salary data is made available and everybody […]

Read More
Biopharmaceuticals
Dividends
Fibonacci Retracement
Fundamental Analysis
Health
HeathCare
Medical
Pharmaceuticals
Technical Analysis
Vaccines
Value Investing
Value Stocks
Volatility

Do GSK’s fundamentals support its value proposition?

For most of the past year, any examination of the Pharmaceutical industry begins and ends with COVID-19 vaccines. Literally, of course, this isn’t true; diseases of all kinds don’t take a holiday during a pandemic, and so development of existing projects for any company in this industry hasn’t stopped, either. Nonetheless, the massive, immediate impact […]

Read More